Legumain is expressed on macrophages in active demyelinating lesions of multiple sclerosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1759-1961|6|3|304-305

ISSN： 1759-1961

Source： CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol.6, Iss.3, 2015-08, pp. : 304-305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression profiles of RNA‐Seq‐based grey matter‐specific genes versus white matter‐specific genes in grey matter lesions of multiple sclerosis

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. 3, 2015-08 ,pp. : 289-298

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multiple sclerosis: a cure or a contradiction?

By  

SIGNIFICANCE, Vol. 1740-9705, Iss. 1, 2011-03 ,pp. : 36-38

John Wiley & Sons Inc

Access to resources Recommend Favorite

Advance of genetics in multiple sclerosis

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. S1, 2015-12 ,pp. : 23-29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Epigenetics in multiple sclerosis

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. S1, 2015-12 ,pp. : 49-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

The pathogenesis of multiple sclerosis

By  

CLINICAL AND EXPERIMENTAL NEUROIMMUNOLOGY, Vol. 6, Iss. S1, 2015-12 ,pp. : 2-22

John Wiley & Sons Inc

Access to resources Recommend Favorite